Form 4: Avita Medical CFO David O'Toole Acquires 1,000 Shares of Common Stock

Sentiment:

SEC Form 4 Filing


Avita Medical's CFO, David O'Toole, purchased 1,000 shares of the company's common stock at $9.90 per share on February 20, 2025.

Summary

  • On February 20, 2025, David O'Toole, the CFO of Avita Medical, Inc., acquired 1,000 shares of common stock.
  • The purchase price was $9.90 per share.
  • Following this transaction, O'Toole directly owns 25,734 shares of Avita Medical's common stock.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. The CFO's purchase of shares suggests confidence, but it's a relatively small transaction.

Positives

  • The CFO's purchase of company stock could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard disclosures required by the SEC when company insiders (officers, directors, or those holding more than 10% of the company's shares) buy or sell the company's securities. These filings are closely watched by investors as they can provide insights into management's perspective on the company's valuation and future prospects.

Stakeholder Impact

  • The CFO's stock purchase may have a minor positive impact on shareholder sentiment.

Key Dates

DateDescription
02/20/2025Date of the transaction: David O'Toole purchased 1,000 shares of Avita Medical's common stock.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.